Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
We have investigated the effects of the phosphodiesterase (PDE) type IV inhibitor rolipram and of the glucocorticoid methylprednisolone on the induction of tumour necrosis factor alpha (TNF‐α) mRNA and protein in brains of rats after peripheral administration of lipopolysaccharide (LPS). After intravenous administration of LPS, a similar time‐dependent induction of both TNF‐α mRNA and protein was observed in rat brain. Peak mRNA and protein levels were found 7 h after administration of LPS. In situ hybridization experiments with a specific antisense TNF‐α riboprobe suggested that the cells responsible for TNF‐α production in the brain were microglia. Intraperitoneal administration of methylprednisolone inhibited the induction of TNF‐α protein in a dose‐dependent manner. A maximal inhibition of TNF‐α protein production by 42.9±10.2% was observed at a dose regimen consisting of two injections of each 30 mg kg−1 methylprednisolone. Intraperitoneal administration of rolipram also inhibited the induction of TNF‐α protein in a dose‐dependent manner. The maximal inhibition of TNF‐α protein production was 96.1±12.2% and was observed at a dose regimen of three separate injections of each 3 mg kg−1 rolipram. In situ hybridization experiments showed that the level of TNF‐α mRNA induced in rat brain by LPS challenge was reduced by intraperitoneal administration of methylprednisolone (2×15 mg kg−1) and of rolipram (3×3 mg kg−1). We suggest that peripheral administration of LPS induces a time‐dependent expression of TNF‐α in rat brain, presumably in microglial cells, and that methylprednisolone and rolipram inhibit LPS‐induced expression of TNF‐α in these cells via a decrease of TNF‐α mRNA stability and/or TNF‐α gene transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532 · cited 1×
“TNF-a is a peptide secreted by macrophages upon stimulation with lipopolysaccharide (LPS), an endotoxin of Gram-negative bacteria (Carswell et al., 1975; Beutler et al., 1985).”
BackgroundLayé, S., Parnet, P., Goujon, E., & Dantzer, R. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90197-x · Cited by 500 · cited 1×
“…meningitis (Frei et al., 1990; Hunter et al., 1992), cerebral malaria (Lucas et al., 1992), administration of endotoxin (Gatti & Bartfai, 1993; Laye et al., 1994), multiple sclerosis (Hofman et al., 1989; Sharief & Hentges, 1991), AIDS dementia complex (Merrill & Chen, 1991) and experimental…”
BackgroundGatti, S., & Bartfai, T. (1993) · Brain Research · doi:10.1016/0006-8993(93)90090-a · Cited by 257
Breder, C. D., Hazuka, C., Ghayur, T., Klug, C., Huginin, M., Yasuda, K., Teng, M., & Saper, C. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11393 · Cited by 226
Cited by
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
The Role of Markers of Inflammation in Traumatic Brain Injury
Woodcock, T., & Morganti-Kossmann, M. C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00018 · Cited by 712
Nucleotide receptors: an emerging family of regulatory molecules in blood cells
Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J. M., Morelli, A., Torboli, M., Bolognesi, G., & Baricordi, O. R. (2001) · Blood · doi:10.1182/blood.v97.3.587 · Cited by 703
Pharmacology of Cloned P2X Receptors
North, R. A., & Surprenant, A. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.563 · Cited by 701
Activation and Regulation of Purinergic P2X Receptor Channels
Coddou, C., Yan, Z., Obsil, T., Huidobro-Toro, J. P., & Stojilkovic, S. S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003129 · Cited by 493
Dual role of tumor necrosis factor alpha in brain injury
Shohami, E. (1999) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00008-8 · Cited by 416
Brilliant Blue G Selectively Blocks ATP-Gated Rat P2X7Receptors
Jiang, L.-H., Mackenzie, A. B., North, R. A., & Surprenant, A. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.1.82 · Cited by 401
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Bartlett, R., Stokes, L., & Sluyter, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008003 · Cited by 393
Nikulina, E., Tidwell, J. L., Dai, H. N., Bregman, B. S., & Filbin, M. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402595101 · Cited by 345
North, R. A., & Jarvis, M. F. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.083758 · Cited by 270
Mori, K., Ozaki, E., Zhang, B., Yang, L., Yokoyama, A., Takeda, I., Maeda, N., Sakanaka, M., & Tanaka, J. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00211-3 · Cited by 215
The hippocampus and TNF: Common links between chronic pain and depression
Fasick, V., Spengler, R. N., Samankan, S., Nader, N. D., & Ignatowski, T. A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.03.014 · Cited by 204
Breese, G. R., Knapp, D. J., Overstreet, D. H., Navarro, M., Wills, T. A., & Angel, R. A. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301468 · Cited by 110
“As LPS increases cytokines in brain (Breder et al, 1994; Buttini et al, 1997; Hagan et al, 1993; Hillhouse and Mosley, 1993; Ilyin et al, 1998; Matalka et al, 2005; Quan et al, 1994), it was next determined if cytokines could indeed be responsible for the LPS/withdrawal protocol sensitization of…”
BackgroundMethodSyed, Y. A., Baer, A., Hofer, M. P., González, G. A., Rundle, J., Myrta, S., Huang, J. K., Zhao, C., Rossner, M. J., Trotter, M. W. B., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201303123 · Cited by 58
“…study because the dose of rolipram that was used to enhance remyelination in the present study (0.5mg/kg/day) is much lower than the dose at which rolipram is effective as an anti ‐ in fl ammatory agent (3mg/kg/day) up to 10mg/kg) (Buttini et al, 1997; Francischi et al, 2000; Laemont et al, 1999).”
Coelho, A.-M., Fioramonti, J., & Bueno, L. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00269-0 · Cited by 31
Metadata
- Authors
- Buttini, M., Mir, A., Appel, K., Wiederhold, K. H., Limonta, S., Gebicke‐Haerter, P. J., & Boddeke, H. W. G. M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1997-12
- Volume
- 122
- Issue
- 7
- Pages
- 1483-1489
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2034867678
- Cited by
- 112
- References
- 4
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.